BIIO (Bionovate Technologies) EV-to-OCF: (As of Sep. 02, 2026)

Bionovate Technologies  (OTCPK:BIIO) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bionovate Technologies's PE Ratio (TTM) for today is calculated as:

Bionovate Technologies's share price for today is $0.0001.
Bionovate Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.008.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Bionovate Technologies EV-to-OCF Related Terms

The historical data trend for Bionovate Technologies's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies EV-to-OCF Chart

Bionovate Technologies Annual Data
	Trend	Jun13	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21
EV-to-OCF		Get a 7-Day Free Trial				129.81	0.00	0.00	0.00	0.00

Bionovate Technologies Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
EV-to-OCF	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

BIIO vs ABT, MDT, SYK: EV-to-OCF Comparison

For the Medical Devices subindustry, Bionovate Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionovate Technologies EV-to-OCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionovate Technologies's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Bionovate Technologies's EV-to-OCF falls into.

Bionovate Technologies EV-to-OCF Calculation

Bionovate Technologies's EV-to-OCF for today is calculated as:

Bionovate Technologies's current Enterprise Value is $0.24 Mil.
Bionovate Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies Business Description